Medical device company Nevro has received approval from the US Food and Drug Administration (FDA) and announced a limited ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

Nevro earned FDA approval and began a limited market release of its HFX iQ spinal cord stimulator with HFX AdaptivAI, the company said Sept. 24.

Nevro announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord ...

Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of ...

Minimally invasive technology would allow for percutaneous placement of a paddle electrodeRenowned pain specialist Dr. Sean Li to present on this ...

Nevro NVRO recently announced the FDA clearance and limited market release of HFX iQ with HFX AdaptivAI, a responsive, personalized pain management platform powering the HFX iQ spinal cord stimulation ...

A drug called bumetanide, which is used to treat edema in people, reduced this cellular swelling and resulting cell death in mice. Mice given the drug after an injury were better able to move their ...

23, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global spinal fusion stimulator ... solutions for spinal cord fusion surgeries.

How did the bodies of animals, including ours, become such fine-tuned movement machines? How vertebrates coordinate the eternal tug-o-war between involuntary reflexes and seamless voluntary movements ...

A new retrospective, multicenter study set out to determine ways to enhance spinal cord stimulation longevity and relate ...

Over the next nine years, Christopher, with the constant support and help of his wife, Dana Reeve, vigorously pursued a cure and pushed for more treatments for spinal cord injuries. The Reeves ...